GuideRx is solving the challenge of delivery of genetic therapies

Rapid discovery of nanoparticles that target new tissues

We can deliver any gene therapy

We have developed a suite of increasingly sensitive methods to track how thousands of drug delivery systems work in vivo. By radically streamlining the pre-clinical ‘pipeline’ used to develop safe nanoparticles, we can rapidly select cutting-edge nanoparticles that deliver genetic drugs to new tissues.

Our Approach: Rapidly Testing Thousands of Nanoparticles Directly In Vivo

High on-target delivery; more efficacy
Low off-target delivery; fewer side effects

Increasing the rate of discovery
15,000 fold